Regeneron Pharmaceuticals has announced a successful trial of REGN-COV2 for coronavirus treatment. The greatest effect of treatment was observed in patients without formed immunity. In case of success, the company is ready to deliver from 70 thousand to 300 thousand doses, intended for treatment, and from 420 thousand to 1,3 million doses, intended for coronavirus prevention.